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Abstract
Nanoneedles display potential in mediating the delivery of drugs and biologicals, as well as 
intracellular sensing and single cell stimulation through direct access to the cell cytoplasm. 
Nanoneedles enable cytosolic delivery, negotiating the cell membrane and the endolysosomal 
system, thus overcoming these major obstacles to the efficacy of nanotherapeutics. The low 
toxicity and minimal invasiveness of nanoneedles has a potential for the sustained non-
immunogenic delivery of payloads in vivo, provided that the development of biocompatible 
nanoneedles with a simple deployment strategy is achieved. Here we present a mesoporous silicon 
nanoneedle array that achieves a tight interface with the cell, rapidly negotiating local biological 
barriers to grant temporary access to the cytosol with minimal impact on cell viability. The 
tightness of this interfacing enables both delivery of cell-impermeant quantum dots in vivo and 
live intracellular sensing of pH. Dissecting the biointerface over time elucidated the dynamics of 
cell association and nanoneedle biodegradation, showing rapid interfacing leading to cytosolic 
payload delivery within less than 30 minutes in vitro. The rapid and simple application of 
nanoneedles in vivo to the surface of tissues with different architectures invariably resulted in the 
localized delivery of quantum dots to the superficial cells and their prolonged retention. This 
investigation provides an understanding of the dynamics of nanoneedles’ biointerface and delivery 
outlining a strategy for highly local intracellular delivery of nanoparticles and cell-impermeant 
payloads within live tissues.
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Vertical arrays of nanoneedles can provide access to the cell cytosol and interact with the 
intracellular environment without eliciting toxicity or altering cell metabolism.1-4 Recent 
advances have indicated that nanoneedles may outperform currently available technology 
for the delivery of nucleic acids3,5,6 and for the intracellular recording and stimulation of 
excitable cells.7 However the widely employed interfacing (i.e., nanoinjection) strategies, 
while suitable for nanoinjection in culture, possess limited translational potential in vivo.4,7-9 
Nanoinjection requires cell activity,10,11 centrifugation,12 AFM operation13 or 
electroporation14 in order to guarantee intracellular interaction. Cell activity is highly 
dependent on cell type and its environment, and requires prolonged interfacing;1 
electroporation is accompanied by high cytotoxicity and immune response,15,16 while 
centrifugation and AFM operation are only applicable to cultures.
Semiconducting nanowires3,17 and carbon nanofibers/nanotubes4,18 constituting the vast 
majority of nanoneedles are not biodegradable and have demonstrated poor in vivo 
biocompatibility. Carbon nanowires can exhibit high cytotoxicity by multiple exposure 
routes and targeting different organs,19,20 leading to diverse pathologies including acute 
inflammation,21 foreign body response22 and cancer.23 These effects can be mitigated 
during synthesis22,23 or before deployment24 but safety concerns remain, especially when 
envisioning a minimally invasive, non-immunogenic treatment. Silicon is a poor biomaterial 
eliciting thrombus formation in contact with blood25,26 and foreign body response 
subcutaneously.27 On the other hand porous silicon (pSi) is a viable candidate for the 
fabrication of biocompatible nanoneedles. It is a biodegradable28 and highly biocompatible 
material,29 employed in vivo for ocular implants,30 as drug delivery vector particulate for 
intravenous injection8,31,32 and tested in humans as a brachytherapy device.33 Porous silicon 
nano- and microparticles uptake studies in culture have demonstrated elevated 
cytocompatibility following internalization.31 Intravenously delivered pSi in vivo can 
distribute across all organs in the body8,34 and be cleared within few weeks,8 without 
causing adverse reactions or eliciting inflammation.32,35 Indeed pSi use in humans has been 
evaluated as safe and risk-free in phase I and phase II clinical trials.33,36
Further development of nanoneedle technologies requires a more critical comprehension of 
the process of nanoinjection in both isolated cells and whole tissues to improve design and 
engineer nanoneedles with optimal nanoinjection potential. Still very little is known 
regarding the dynamics and localization of nanoneedles and their payload upon interfacing 
with cells. The very penetration of nanoneedles across the cell membrane is hotly 
debated.1,3,37,38
A growing body of evidence indicates that in vitro nanoinjection enables the crossing of the 
membrane barrier and allows for the direct colocalization with intracellular organelles and 
cytosolic structures.1-3,5,13 The sudden drop in force that occurs when applying a 
nanoneedle, has been interpreted as the crossing of a physical barrier, the cellular 
Chiappini et al. Page 2
ACS Nano. Author manuscript; available in PMC 2016 February 01.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
membrane.13 Confocal microscopy reveals that nanoneedles are often co-localized with the 
cytosol or nucleus.3 In addition, nanoneedles can effectively deliver labile biological 
therapeutic agents in their active form to the nucleus and/or the cytosol, confirming their 
ability to efficiently reach the intracellular space.1,3 The buildup of large forces at the 
interface between the cell membrane and the high aspect ratio needle structure, has recently 
been proposed as the mechanism leading to self-puncturing and cytosolic display, 39 with 
self-puncturing being directly observed in mammalian cells.10
Conflicting evidence suggests that nanoneedles may simply be tightly associated to the cell 
membrane, but not cross it completely. For example, the perinuclear fluorescent signal often 
associated with nanoneedle mediated delivery implies that a large portion of the payload was 
internalized through a classic endocytic pathway.3 Furthermore sensing of intracellular 
electrical activity in several instances requires the initial application of a voltage pulse, to 
first induce membrane poration.37 Electron microscopy imaging of in vitro nanoinjection 
reveals that short nanopillars of solid silicon appear unable to cross the plasmalemma.38 
Longer thinner nanowires instead, can significantly invaginate the plasma membrane40,41 or 
be internalized by the endolysosomal system as isolated broken fragments.42 Little is known 
about the impact and cytotoxicity of nanoneedles inserted within cells and tissues; however 
cells grown over nanoneedles present unaltered respiratory metabolism, membrane integrity, 
proliferation, and housekeeping gene expression.1
Nanoinjection has the unique potential to deliver nanoparticles to a specific set of cells in a 
localized region, without involving the vast majority of the tissue. The study reported here 
employs our recently developed class of porous silicon nanoneedles6 to investigate their 
biointerface and the cytosolic delivery of nanoparticles. These porous silicon nanoneedles 
negotiate the endolysosomal system allowing sensing intracellular pH without inducing 
apoptosis. Dissecting the kinetics of the nanoneedles’ interface and of quantum dots delivery 
yields insight into their cytosolic interaction and any nuclear envelope remodeling. The 
kinetic study also highlights the similarities and differences in interfacing and delivery 
existing between forceful nanoinjection compared to the seeding of cells over nanoneedles. 
Finally nanoinjection in mice demonstrates localized delivery of nanoparticles to the 
superficial layers of architecturally different mammalian tissues. The evolution of the 
nanoneedle biointerface and the dynamics of payload delivery are studied and the 
nanoneedles are applied as a system for the localized two-dimensional delivery of 
nanoparticles to the cell in live tissues of widely different architectures.
Results
Porous Silicon Nanoneedles
The synthesis of pSi nanoneedle arrays (nanoneedles) combined microfabrication with metal 
assisted chemical etching. The needles were arranged in a square lattice with 2 μm pitch, 
were 5-7 μm tall, had a tip diameter <50 nm, a 600 nm base and 50% porosity with 10-15 
nm pore size (Figure 1 a). A single process yielded a 100 mm wafer uniformly covered with 
needles. Photolithography followed by reactive ion etch defined the desired pattern on a thin 
film of low stress nitride over the silicon substrate (Figure 1 b). Electroless deposition 
formed dendritic Ag nanoparticles selectively on the exposed silicon between the patterned 
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areas. Metal assisted chemical etch of this substrate43 yielded pSi pillars which reactive ion 
etching shaped into conical nanoneedles. This high throughput and parallelized fabrication 
strategy did not require direct writing and granted control over the geometry, arrangement, 
and nanoscale porosity of the needles.
In pursuing optimal biocompatibility and interfacing, our design choices were informed by 
the available literature and by our experience with pSi nanomaterials. A smaller tip diameter 
provides a tighter cell-needle interface38 and favors the delivery of drugs across the cell 
membranes while reducing cytotoxicity.1,9,13 Our previous investigations of pSi 
microparticles for systemic drug delivery indicated that a 10 nm pore size enabled optimal 
loading of hydrophilic quantum dots with 6 nm diameter44 while the 50% porosity provided 
a 600-fold increase in surface area over solid structures and allowed full degradation within 
a day.45
Nanoinjection provides safe intracellular interfacing and delivery
Nanojection was performed either by seeding cells over an array of nanoneedles 
(nanoneedles on bottom, nN-B), or by forcibly applying the nanoneedles from the top of the 
cell monolayer (nanoneedles on top, nN-T). Forcible application employed a centripetal 
acceleration of 100 rcf on a 70 mg chip, leading to an effective force of 68 mN shared across 
the 1.6 × 107 nanoneedles present on the chip, effectively applying a theoretical load of 4.25 
nN per needle. This force is compatible with nanoneedle intracellular penetration, being 
higher than the threshold identified for a nanoneedle to cross a plasma membrane (0.5nN to 
2nN).9 We have previously observed that nanoinjection does not affect viability or 
proliferation of cells.6
A pH sensor was built by covalent attachment of a pH-sensitive fluorophore (fluorescein 
isothiocyanite, FITC) and a reference fluorophore (AlexaFluor 633, AF633) to the 
nanoneedles. The response of this sensor to pH was measured by ratiometric fluorescence 
and was found to be linear in the biologically relevant range of pH (6.1 to 7.9, Figure S1). 
Upon nanoinjection in vitro, this sensor mapped intracellular pH (pHi) with single cell 
resolution alongside extracellular pH (pHe). The OE33 oesophageal adenocarcinoma cell 
line displayed significant quenching of FITC fluorescence in correspondence of most 
nanoneedles underlying cells, corresponding to a ratiometric measurement of pH 6.7 (Figure 
2 a, c, d). Conversely the nanoneedles tested with HET-1A cells displayed a ratiometric 
fluorescence equivalent to pH 7.2 (Figure 2 b, c, d). Both findings were in agreement with 
the pHi measured for OE33 and HET-1A by BCECF (Figure S2). The pH 7.4 measured for 
free standing nanoneedles was consistent to the pHe of the culture medium (Figure 2c, d). In 
OE33 cultures, a red nanoneedle would be sensing a pH equivalent to pHi, while a yellow/
green one would be sensing pHe. Upon nanoinjection the vast majority of nanoneedles 
underlying OE33 cells sensed pHi (Figure 2 a).
Loading a fluorescent payload within the mesoporous network of the pH sensing 
nanoneedles enabled combined intracellular sensing and delivery. The vast majority of cells 
in culture displayed cytosolic localization of the fluorescent payload (Figure 2 e). All cells 
displaying cytosolic fluorescence were also underpinned by nanoneedles sensing pHi. The 
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intracellular delivery and sensing appeared to have a minimal impact on cell viability, as 
evidenced by the few apoptotic cells in Figure 2 e (green nuclei indicated by blue arrows).
Exploring the cell-nanoneedle interface
Following nanoinjection, confocal microscopy revealed intact nanoneedles interfaced to the 
cytosol of cells. Several nanoneedles co-localized with the nuclear region regardless of 
injection strategy (Figure 3 a-e). In agreement with the pHi measurements, confocal 
microscopy suggested a tight cytosol-nanoneedle interface, showing nanoneedles several 
hundreds of nanometers above the red membrane staining, but could not provide detailed 
information regarding their interaction with subcellular structures (i.e. cytoskeleton, 
vesicles, etc.) or their mutual positioning with respect to the nucleus.
To visualize the cell-nanoneedle interface at higher resolution, we processed the cells using 
a slice-through imaging approach combined with dual beam Focused Ion Beam-Scanning 
Electron Microscopy (FIB-SEM) (Figure 3 b,e, Movies S1-S8). In agreement with the 
nanoneedles’ ability to sense pHi, FIB-SEM suggested that nanoneedles tightly interfaced 
with the cytosol (Figure 3 b,e, Figure S3). Several nanoneedles seemed to be pinned to the 
nucleus, with the nuclear envelope being remodeled to wrap around each nanoneedle (Figure 
S4, Movies S3, S7). Importantly, the needles localizing within the non-nuclear areas of the 
cell never appeared to emerge from the far side of the cell (Figures S3, S5, Movies S1-S3, 
S5-S7). Regardless of the nanoinjection strategy (nN-B or nN-T), cells exhibited flexible 
nuclear and plasma membrane rearrangements in response to the puncturing needle.
Confocal microscopy and SEM-FIB analysis showed that as early as one hour after seeding, 
the tip of the nanoneedles appeared to interface with the cytosol and in close proximity to 
the nucleus (Figure 3 d-i, Figure S6 a, Movie S1). Quantification of segmented SEM-FIB 
images confirmed that the needles progressively increased their interfacing with the cytosol 
while reducing their distance to the nucleus (Figure 3 h, i). After 8 hours the nanoneedles 
interfaced with the cytosol for a depth of 2 μm and appeared to have contacted the nuclear 
envelope, inducing nuclear remodeling (Figure 3 e, g-i, Movies S1-S8). Immediately after 
seeding, cells retained the typical spherical shape of the early stages of cell spreading (figure 
3 d-g, Movies S1, S2). At later time points, the cells continued to extend and spread, 
wrapping the tips of their filopodia to the neighboring needles (Figure S6).
Throughout the process of interfacing the nanoneedles experienced progressive degradation, 
effectively increasing their porosity and reducing their mechanical stability. Inspection of 
the nanoneedles 8 hours after injection revealed they retained their morphology. After 15 
hours, nanoneedles were visibly degraded (Figure S7) until only the solid stump of the 
needles remained by 72 hours. At this time no recognizable nanostructure resembling the 
nanoneedles could be found within the cells. (Figure 3 d-g, Figure S8, Movies S4, S8). The 
electron dense regions observed in the cytosol likely represent areas of high Si concentration 
that arose from the degradation of the nanoneedles (Figure 3 e, g, Movies S4, S8). Similarly, 
the confocal micrographs of nanoneedles covalently-tagged with a fluorescent dye displayed 
intracellular regions of green fluorescence, likely originating from the dye initially 
conjugated to the needles (Figure 3 d).
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Cytosolic nanoinjection of quantum dots
Fluorescent 6 nm hydrophilic quantum dots were loaded in the porous structure of the 
nanoneedles (Figure S9 a) and nanoinjected into cells. Confocal microscopy confirmed that 
quantum dots diffused rapidly throughout the cytosol of all cells (Figure 4 a-b). SEM-FIB 
confirmed that quantum dots localized both on the nanoneedles and within the cytosol of 
nanoinjected cells, but not within the nucleus (Figure 4 c, Figure S10). Transmission 
electron microscopy coupled with elemental analysis validated the intracellular presence of 
quantum dots and their free accumulation in the cytosol outside of the membranous 
organelles constituting the endolysosomal system (Figure 4 d, Figure S11).
The same amount of quantum dots delivered in solution could not be detected intracellularly 
by SEM-FIB and generated limited fluorescence associated with the cell body (Figure 4 a,c), 
thus confirming that the delivery of quantum dots was directly mediated by the nanoneedles. 
Both nN-B and nN-T showed cytosolic accumulation of quantum dots as early as 30 minutes 
following nanoinjection (Figure 4 b) and reached a plateau within 1 hour. nN-B samples 
retained 69% of the payload at 24 hours, compared to 18% of nN-T (Figure 4 a, b). The 
delivery of quantum dots occurred more rapidly for nN-T, likely due to the earlier, deeper 
interfacing of the nN-T nanoinjection, which at 1 minute displayed a similar profile to nN-B 
at 8 hours (Figure 2). While the average peak delivery was similar for the two approaches, 
nN-B delivery was more uniform across cells, especially at shorter times (Figure 4 a,b). 
While the nN-T cells were adherent on the substrate for at least 24h prior to nanoinjection, 
the nN-B cells needed additional time to initially adhere and spread to the nanoneedles. In 
agreement with our prior observations during the exploration of the cell-nanoneedle 
interface, these results may reflect the more uniform and gradual interaction with the cytosol 
for the nN-B (Figure 4 a,b).
Bovine serum albumin (BSA) and siRNA were simultaneously loaded into nanoneedles, 
showing uniform distribution throughout the entire porous matrix (Figure S9 b-d). In both 
nanoinjection strategies the BSA and siRNA payloads were delivered to the cytosol 
similarly to what was observed with quantum dots (Figure S12).
Nanoinjection of quantum dots to muscle and skin
In vivo nanoinjection of quantum dots to an exposed muscle and two skin locations allowed 
evaluation of localized nanoparticle delivery in mice. Regardless of the tissue, quantum dots 
were confined to a limited volume associated with the surface layer contiguous to the site of 
nanoinjection (Figure 5 a,b Figure S13). Quantum dot fluorescence was observed originating 
from the cytosolic region of cells located at the surface (Figure 5 a), and TEM confirmed the 
presence of quantum dots associated with cells (Figure 5 c).
In skin and muscle, nanoinjection left a square fluorescent mark at the delivery site, which 
replicated the geometry of the nanoneedle chip (Figure 5 d-f). Further confirming delivery 
within the tissue, nanoinjected quantum dots were retained for up to 100 hours around the 
injection site (Figure 5 f). By comparison quantum dots delivered through a flat silicon chip 
completely dispersed in less than 24 hours (Figure S14).
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Discussion
Porous silicon nanoneedles can efficiently load a nanoparticle payload and direct its delivery 
to the cells in a localized superficial area of tissue. The nanoneedles’ ability to sense 
intracellular pH and direct cytosolic delivery of different payloads (nanoparticles, dyes, 
proteins, nucleic acids) combined with the limited occurrence of apoptosis support the 
available literature to indicate the efficacy, minimal invasiveness, and safety potential of 
nanoinjection.
Nanoinjection of quantum dots to the cell cytosol occurred rapidly after interfacing with the 
cell. The nN-B nanoinjection relied on active cell processes for minimally disruptive 
intracellular delivery. Conversely nN-T proved to be a viable option for nanoinjection in 
vivo, as it delivered the payload to the cells’ cytosol through a rapid and forcible interfacing. 
During nanoinjection the needles progressively interfaced with the cytosol while the cell 
nucleus remodeled to minimize or avoid interfacing. This display of active cellular 
movement subsequent to needle penetration was a further confirmation of the low impact of 
nanoneedles on cell metabolism.
The superficial intracellular delivery observed in vivo was extremely localized to the area 
interfaced by the needles and did not reach the bulk of tissues or cross tissue barriers such as 
the stratum corneum of the skin. The local nature of the interaction suggests that 
nanoneedles-mediated delivery or sensing would only occur at the immediate region of 
interfacing, with minimal involvement of the remaining tissue.
Microneedles typically require a high insertion velocity to deliver a payload in vivo.46 
Conversely our nanoinjection strategy has very low impact on the tissues while showing 
prolonged retention of the payload at the delivery site. The minimally invasive, uniform and 
controlled access to the cytosol of a large number of cells within a defined or patterned area, 
combined with the ability to deliver to and sense the intracellular space with the potential to 
discriminate cancer (OE33) from healthy (Het-1A) cellular microenvironment can pave the 
way towards nanoscale interaction and interrogation of cells within complex architectures 
for the assessment of tissue pathologies at the single cell level.
Methods
An expanded methods section covering the details of all methods employed in this study is 
available as supplementary material.
Nanoneedles fabrication
A layer of 160nm of low-pressure chemical vapour deposition low stress silicon nitride was 
deposited on boron doped p-type, 100 mm, 0.01 0.01 Ω-cm Si wafers. The photolithographic 
pattern consisting of 600 nm diameter disks with a 2 μm pitch was transferred on the 
photoresist coated substrate. Pattern transfer limited to the silicon nitride layer was 
performed by CF4 reactive ion etching. The photoresist was then stripped.
Electroless deposition of Ag on the patterned Si wafer occurred in an HF solution of 0.02 M 
AgNO3 20 ml 49% HF, 75 ml H2O, following the substrate cleaning in 10% HF. The 
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substrate was rinsed and dried. Metal assisted chemical etch occurred in 80 ml HF, 316 ml 
H2O and 4 ml of H2O2 for 8 minutes 30 seconds followed by reactive ion etch in SF6 
plasma. The substrate was then diced in 8 × 8 mm chips, and oxidized by O2 plasma.
Nanoneedles on bottom interfacing in vitro (nN-B)
The sterilized chip carrying the nanoneedles (70% v/v ethanol in deionized water, 1 hour) 
was dried and UV irradiated for 1 hour. The chip was placed at the bottom of a 24 well plate 
and rinsed three times with PBS. The desired density of cells (typically around 1 × 105 cells) 
was seeded over the needles and the well plate was returned to the incubator.
Nanoneedles on top interfacing in vitro (nN-T)
Cells were seeded in a 24 well plate at 5 × 104 cells/well and incubated for 24-48 hours until 
reaching >60% confluence. The cell culture medium was exchanged with 3 ml of fresh 
medium and the nanoneedle chip was immersed in medium face down. The plate was 
transferred to a swinging bucket centrifuge with appropriate counterweight and spun at 100 
rcf for 1 minute. If the experiment required incubation for longer than 30 minutes, the chips 
were flipped face up at 30 minutes.
Quantum dots delivery
Nanoneedles loaded with quantum dots were interfaced with HeLa cells, either nN-T or nN-
B. The control samples were interfaced nN-B and the same volume of quantum dots as for 
the nanoneedles were added to the medium together with the cells. At each timepoint the 
samples were washed five times in PBS and then fixed in 4% v/v paraformaldehyde in PBS 
for 15 minutes at RT. The samples were further washed in PBS, stained with DAPI and 
finally mounted on coverslips. A single z-slice immediately above the nanoneedles tips was 
acquired for each sample on a leica SP5 inverted laser scanning confocal microscope and the 
area normalized fluorescence intensity of 50 cells for each of three images was evaluated 
using Volocity (Perkin Elmer, USA). Three randomly acquired images per sample were 
analysed. Experiments were performed in triplicate, data is reported as the mean with 
standard error of the mean.
Combined pH sensing, fluorophore delivery and caspase activity monitoring
Nanoneedles were functionalized for pH sensing and delivery (supplementary materials). 
Cells were nN-T nanoinjected, and allowed to equilibrate for 30 minutes in an incubator. 
The medium was then completely replaced adding the of the caspase 3/7 detection assay in 
fresh HEPES buffered DMEM without phenol red or other supplementation. The assay was 
incubated for 30 minutes in a cell culture incubator. In this assay, caspase activity cleaves a 
substrate allowing it to bind the nuclear DNA and enhance its fluorescence. Caspase activity 
is this characterized by intense green nuclear fluorescence.
Cells were then imaged by confocal microscopy. A single z-plane was imaged for the FITC 
emission and the AF 633 emission, maintaining laser power, photomultiplier gain and 
wavelength acquisition window constant across all samples. Caspase activity and 
fluorophore delivery were imaged in a different z-plane than the pH, this z-plane lying 
above the tip of the nanoneedles.
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The pH images were analyzed in a custom Matlab program that identified the nanoneedles 
from the background and calculated the fluorescence emission ratio of FITC/AF633 
singularly for each nanoneedle, and then averaged it over a pre-selected region of interest.
Nanoneedles on top interfacing in vivo
Animal studies were performed in accordance with the guidelines of the Animal Welfare 
Act and the Guide for the Care and Use of Laboratory Animals based on approved protocols 
by Houston Methodist Research Institute’s Institutional Animal Care and Use Committees. 
APTES modified nanoneedles (supplementary materials) were thoroughly cleaned with 
ethanol and dried under UV and then loaded with 660 nm CdTe quantum dots (PlasmaChem 
GmbH). The solution was allowed to dry on the needles and then was immediately used for 
experiments. The loaded nanoneedles were imprinted on the skin (back or ear) and muscle 
of male athymic nude mice (n=3) (NCr-Fox1nu; 4-6 week old). Animals were anesthetized 
and directly nanoinjected in the case of skin. For muscle, the superficial gluteal and lumbar 
muscles were exposed by surgical incision, gently elevating the fascia from the underlying 
muscle. The nanoneedles were inserted in direct contact with the lumbar and gluteal muscle 
on the right side. Nanoneedles were removed within two minutes from the insertion. Mice 
were imaged using a Xenogen IVIS200 housed within the preclinical imaging core facility at 
HMRI. Mice were imaged at pre-determined times to study the release kinetics of quantum 
dots from the site of treatment. Data was quantified with Living Image 4.1.
Histology
Histological analysis for H&E and fluorescence imaging on muscle, skin, and ear was 
performed. Tissues were harvested and fixed in formalin prior to embedding into paraffin. 
Paraffin sections were then deparaffinized with xylene and re-hydrated with decreasing 
concentrations of ethanol followed by washings in water. Staining occurred immediately 
after this step either with H&E or with AF488 WGA and DAPI for fluorescence imaging of 
Qdots and then coverslipped. Furthermore, unstained sections of tissues were used to 
quantify quantum dot fluorescence.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Porous silicon nanoneedles and their fabrication process. (a) Scanning electron micrographs 
of a uniform array of conical pSi nanoneedles, with <100 nm tip diameter, 600 nm base 
diameter, 5 μm length and 2 μm pitch. (b) Schematic diagram of the nanoneedle fabrication 
process. i-Deposition of low stress nitride thin film by low pressure chemical vapour 
deposition. ii-Patterning of 600 nm nitride disks. iii-Selective deposition of Ag dendrides 
over the exposed silicon by electroless deposition from AgNO3 salts. iv- Metal assisted 
chemical etch in oxidizing solution of HF to obtain pSi pillars interspersed with pSi 
nanowires. v- Reactive ion etching in SF6 plasma to shape pillars into conical nanoneedles 
and remove nanowires.
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Figure 2. 
Nanoneedles mediate simultaneous intracellular pH sensing and delivery to viable cells. (a-
b) nanoneedles simultaneously functionalized with FITC (green) and AF 633 (red) sense 
intracellular and extracellular pH for OE 33 (a) and Het-1A (b) cells (nucleus in blue, 
membrane in magenta) in culture. (c) magnifications of the outlined insets from panels (a,b) 
showing the different optical readout for OE-33 and Het-1a cells. (d) Quantification of 
intracellular and extracellular pH as measured by nanoneedles. (e) Caspase 3/7 activity assay 
in conjunction with intracellular pH measurement and delivery by confocal microscopy. The 
confocal micrograph shows limited nuclear localization of caspase 3/7 (first panel-nuclear 
green stain, and blue arrows-main panel), universal cytosolic delivery to cells (white) and 
sensing of lower intracellular pH (red nanoneedles) compared to extracellular (yellow 
nanoneedles) in OE 33 cells. The green and white micrographs for the delivery and caspase 
activity are acquired at the same z-plane above the nanoneedles; the red and green 
micrographs for pH measurements are acquired at the same z-plane within the nanoneedles.
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Figure 3. 
The cell-nanoneedle interface upon nanoinjection. (a-c) nN-T nanoinjection showing 
cytosolic interfacing and exclusion from the nucleus 1 minute following nanoinjection. (d-f) 
Temporal evolution nN-B nanoinjection showing progressive cytosolic interfacing and 
nuclear exclusion with associated remodeling of nuclear envelope. (a, d) Laser scanning 
confocal micrographs at the timepoints indicated. Cell membrane in red, nuclei in blue, and 
nanoneedles in green. (b, e) FIB-SEM cross sections of nanoinjected cells. (c, f) 54° tilt 
SEM micrographs showing retained cell morphology. (g) Three dimensional reconstruction 
FIB-SEM slice through segmentation at different times for nN-B nanoinjection. 
Nanoneedles in blue, cell membrane in purple, nuclear envelope in yellow and electron 
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dense areas attributed to Si in green (72 hours). (h) Quantification of the nanoneedles depth 
of cytosolic interfacing, measured as the distance between the tip of the nanoneedle and the 
underlying cell membrane. (i) Quantification of the distance of nanoneedles from the 
nucleus, measured as the distance between the tip of a nanoneedle and the cell nucleus. 
*p<0.05, **p<0.01.
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Figure 4. 
Nanoinjection of quantum dots. (a) Confocal micrograph of cells nanoinjected with 570 nm 
emission quantum dots at 2 hours following interfacing. Control represents cells grown on 
nanoneedles with quantum dots added in solution. Cell nuclei in blue, quantum dots in 
yellow. (b) Quantification of quantum dots release within cells as a function of time for the 
three delivery strategies depicted in panel (a) ***p<0.001 for nN-B Vs nN-T. (c) FIB-SEM 
cross sections of cells nanoinjected with quantum dots (nN-B) and empty nanoneedles with 
quantum dots in solution (control). The loaded nanoneedles deliver quantum dots to the 
cytosol (indicated by red arrows). N indicates the nucleus and C the cytosol. (d) TEM 
micrographs of ultrathin (90 nm) sections of cells nanoinjected with quantum dots (nN-B, 
nN-T) and empty nanoneedles with quantum dots in solution (control). Red arrows indicate 
some of the larger aggregates of quantum dots.
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Figure 5. 
In vivo delivery of quantum dots by nN-T. (a) Immunofluorescence histology of the cross 
section of tissues nanoinjected with quantum dots compared to untreated tissue. Quantum 
dots in red, Cell membrane in green, cell nuclei in blue. (b) Quantification of quantum dots 
delivery through fluorescence of histological cross sections such as the ones depicted in 
Figure S10. All tissues show a significant increase in fluorescence upon nanoinjection. 
***p<0.001, *p<0.05. (c) Transmission electron micrograph of the cross section of the 
muscle tissue treated with nanoneedles. Red arrows indicate quantum dot accumulations. (d-
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e) Fluorescent live imaging of the muscle (d) and skin (e) nanoinjection site. (f) 
Longitudinal live animal fluorescent imaging of the nanoinjection site for muscle and skin, 
showing prolonged retention of the quantum dots at the delivery site for up to 100 hours. (g) 
Quantification of the fluorescent imaging showing the amount of dye that is dispersed away 
from the delivery site as a function of time.
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